Q2 Solutions Collaborates with University of Texas Medical Branch to Accelerate COVID-19 Vaccines

March 25, 2020

Applied Clinical Trials

Q2 Solutions, a clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, announced its collaboration with the University of Texas Medical Branch to develop a novel assay for COVID-19 tests. Once a viable assay is developed, Q2 Solutions labs will produce it for use in clinical trials to determine the effectiveness of a COVID-19 vaccine.

For more information, click here.

Related Content:

News